Cufence

Cufence is a medication containing Trientine Dihydrochloride, used for managing certain medical conditions. This oral medication is designed to support specific therapeutic needs, offering a reliable treatment option.

Cufence, containing Trientine Dihydrochloride, is primarily used for the management of conditions related to copper accumulation in the body. It works by binding to copper, facilitating its removal from the body. This medication is often prescribed for long-term use to maintain copper levels within a safe range.

Common effects of Cufence may include gastrointestinal discomfort, such as nausea or stomach pain. Some users might experience dizziness or a metallic taste in the mouth. These effects are generally mild and may subside as the body adjusts to the medication.

Cufence should be taken exactly as directed by a healthcare provider. It is important to follow the prescribed dosage and schedule to ensure optimal effectiveness. Patients should avoid taking this medication with food, as it can interfere with absorption. Regular monitoring of copper levels may be necessary during treatment.

Cufence may interact with certain medications, including those that affect stomach acid production or other chelating agents. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it may exacerbate side effects.